openPR Logo
Press release

United States Probiotic IBS Supplements Market Growth Opportunities & Industry Analysis | Major Players 2025 - The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited

09-10-2025 01:10 PM CET | Food & Beverage

Press release from: DataM intelligence 4 Market Research LLP

Probiotic IBS Supplements Market

Probiotic IBS Supplements Market

"Global Probiotic IBS Supplements Market reached US$ 29.12 million in 2023 and is expected to reach US$ 48.79 million by 2031, growing with a CAGR of 7.65% during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/probiotic-ibs-supplements-market?sp

United States

Recent Launches and Investments

✅ In July 2025, Culturelle (DSM) launched a new line of probiotic supplements specifically targeting IBS symptoms, featuring clinically validated strains.

✅ In March 2025, Align Probiotics introduced an advanced IBS-focused formulation with enhanced gut microbiome support, backed by $15 million in venture funding.

Mergers and Acquisitions

✅ In August 2025, Nestlé Health Science acquired a U.S.-based probiotic startup specializing in IBS supplements to expand its gastrointestinal health portfolio.

✅ In May 2025, Procter & Gamble partnered with a biotech firm to co-develop next-generation probiotic formulations for IBS management.

Japan

Recent Launches and Investments

✅ In August 2025, Morinaga Milk Industry launched a functional probiotic supplement targeting IBS relief and digestive health for Japanese consumers.

✅ In April 2025, Yakult expanded its probiotic product range with an IBS-focused supplement containing clinically validated strains for gut health.
Mergers and Acquisitions

✅ In July 2025, House Foods partnered with a U.S. probiotic company to co-develop IBS-targeted supplements for the Japanese market.

✅ In June 2025, Asahi Group Holdings acquired a domestic probiotic supplement manufacturer to strengthen its digestive health portfolio.

Probiotic IBS Supplements Market: Drivers

The probiotic IBS supplements market is experiencing significant growth as consumers increasingly seek targeted solutions for digestive health and irritable bowel syndrome management. These supplements deliver specific probiotic strains that help regulate gut microbiota, reduce bloating, and improve bowel regularity. Rising awareness about the role of gut health in overall wellness is driving demand for clinically backed, strain-specific products. Convenient formats such as capsules, powders, and chewables are enhancing adoption among diverse consumer groups. With growing focus on preventive healthcare and functional nutrition, probiotic IBS supplements are gaining traction in both retail and healthcare channels.

Advancements in probiotic formulation, including high-potency strains and combination therapies, are improving efficacy and symptom relief for IBS patients. The expansion of e-commerce, pharmacy chains, and health stores is increasing accessibility and market reach. Marketing campaigns highlighting scientific validation, digestive wellness, and immunity support are boosting consumer confidence and adoption. Rising interest in personalized nutrition and gut-focused healthcare is driving product innovation and differentiation. As awareness of digestive health continues to grow globally, the probiotic IBS supplements market is poised for sustained growth and increased consumer acceptance.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/probiotic-ibs-supplements-market?sp

Probiotic IBS Supplements Market: Major Players

The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Pure NSM - Nutritional Supplement Manufacturers, Inc., Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd and

Segment Covered in the Probiotic IBS Supplements Market:

➥ By Strain: Lactobacillus, Bifidobacterium, Others
➥ By Form: Tablet, Capsules, Liquid, Powder, Others
➥ By Distribution Channel: Supermarkets & Hypermarkets, Pharmacy/Health Stores, Online Stores, Others
➥ By End-User: Infants, Children, Adults, Seniors

Research Process:

Both primary and secondary data sources have been used in the 55 Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Probiotic IBS Supplements Market Research Industry:

➠ Who leads the Probiotic IBS Supplements industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Probiotic IBS Supplements market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Probiotic IBS Supplements market growth?
➠ What are the dominant sales and distribution strategies in the Probiotic IBS Supplements industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=probiotic-ibs-supplements-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Probiotic IBS Supplements Market Growth Opportunities & Industry Analysis | Major Players 2025 - The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited here

News-ID: 4177503 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Autonomous Data Platform Market to Reach USD 14.96 Billion by 2032, Report by DataM Intelligence
Autonomous Data Platform Market to Reach USD 14.96 Billion by 2032, Report by Da …
Overview of the Autonomous Data Platform Market The Autonomous Data Platform (ADP) market is witnessing rapid growth, driven by digital transformation and the increasing need for real-time data analytics. ADPs use Artificial Intelligence (AI) and Machine Learning (ML) to automate data management, enabling businesses to make faster, data-driven decisions while minimizing human intervention. These platforms enhance operational efficiency, reduce errors, and allow enterprises to focus on strategic initiatives. ADPs are increasingly
Global 6G Technology Market to Reach USD 9.03 Billion by 2032, Report by DataM Intelligence
Global 6G Technology Market to Reach USD 9.03 Billion by 2032, Report by DataM I …
Overview of the Global 6G Technology Market The 6G technology market represents the next frontier in wireless communication, promising unprecedented advancements in speed, connectivity, and intelligence. Building upon the foundation laid by 5G, 6G aims to deliver peak data rates exceeding 1 terabit per second, ultra-low latency, and seamless integration of artificial intelligence (AI) and quantum-resistant encryption. These capabilities are set to revolutionize industries such as healthcare, automotive, manufacturing, and entertainment
Spinal Muscular Atrophy Treatment Market to Reach USD 20.06 Billion by 2033, Report by DataM Intelligence
Spinal Muscular Atrophy Treatment Market to Reach USD 20.06 Billion by 2033, Rep …
Overview of the Spinal Muscular Atrophy Treatment Market Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by progressive muscle weakness, leading to severe physical disability and, in many cases, early death. The advent of innovative therapies has significantly altered the treatment landscape for SMA, offering hope for improved patient outcomes. Gene therapies, such as onasemnogene abeparvovec (Zolgensma), nusinersen (Spinraza), and risdiplam (Evrysdi), have demonstrated efficacy in increasing survival rates
United States Prime Editing and CRISPR Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Prime Editing and CRISPR Market 2025 | Growth Drivers, Key Players …
Market Size and Growth Prime Editing and CRISPR Market is estimated to grow at a CAGR of 24.1% during the forecast period (2024-2031). Key Development: United States: Recent Industry Developments ✅ July 2025 - Prime Medicine announced an additional investment of up to $24 million from the Cystic Fibrosis Foundation to advance gene editing therapy targeting the G542X mutation, a prevalent cystic fibrosis-causing mutation with no current therapies. ✅ July 2025 - CRISPR

All 5 Releases


More Releases for IBS

Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs. 👉 Download our latest market insights:
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide. A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning. This also includes consulting services concerning railway systems issues, such as travel
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011. The new bulkers, each with a capacity of 176,000 dwt, will be equipped